Apollo Medical Holdings Inc
NASDAQ:ASTH

Watchlist Manager
Apollo Medical Holdings Inc Logo
Apollo Medical Holdings Inc
NASDAQ:ASTH
Watchlist
Price: 25.12 USD 2.78% Market Closed
Market Cap: 1.3B USD

Intrinsic Value

The intrinsic value of one ASTH stock under the Base Case scenario is 48.67 USD. Compared to the current market price of 25.12 USD, Apollo Medical Holdings Inc is Undervalued by 48%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ASTH Intrinsic Value
48.67 USD
Undervaluation 48%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Apollo Medical Holdings Inc

What is Valuation History?
Ask AI Assistant
What other research platforms think about ASTH?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is ASTH valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Apollo Medical Holdings Inc.

Explain Valuation
Compare ASTH to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about ASTH?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
Apollo Medical Holdings Inc

Balance Sheet Decomposition
Apollo Medical Holdings Inc

Current Assets 883.6m
Cash & Short-Term Investments 463.4m
Receivables 397m
Other Current Assets 23.2m
Non-Current Assets 1.4B
Long-Term Investments 27.4m
PP&E 90.1m
Intangibles 1.1B
Other Non-Current Assets 87.8m
Current Liabilities 629.9m
Accounts Payable 302.9m
Accrued Liabilities 37.3m
Other Current Liabilities 289.8m
Non-Current Liabilities 831.7m
Long-Term Debt 1B
Other Non-Current Liabilities -170.3m
Efficiency

Free Cash Flow Analysis
Apollo Medical Holdings Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Apollo Medical Holdings Inc

Revenue
2.9B USD
Cost of Revenue
-2.6B USD
Gross Profit
297m USD
Operating Expenses
-221.8m USD
Operating Income
75.2m USD
Other Expenses
-65.6m USD
Net Income
9.5m USD
Fundamental Scores

ASTH Profitability Score
Profitability Due Diligence

Apollo Medical Holdings Inc's profitability score is 44/100. The higher the profitability score, the more profitable the company is.

Sustainable 3Y Average Gross Margin
Healthy Gross Margin
Low 3Y Average Operating Margin
Low 3Y Average Net Margin
44/100
Profitability
Score

Apollo Medical Holdings Inc's profitability score is 44/100. The higher the profitability score, the more profitable the company is.

ASTH Solvency Score
Solvency Due Diligence

Apollo Medical Holdings Inc's solvency score is 39/100. The higher the solvency score, the more solvent the company is.

Long-Term Solvency
Short-Term Solvency
Positive Net Debt
Average D/E
39/100
Solvency
Score

Apollo Medical Holdings Inc's solvency score is 39/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ASTH Price Targets Summary
Apollo Medical Holdings Inc

Wall Street analysts forecast ASTH stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ASTH is 38.42 USD with a low forecast of 26.26 USD and a high forecast of 56.7 USD.

Lowest
Price Target
26.26 USD
5% Upside
Average
Price Target
38.42 USD
53% Upside
Highest
Price Target
56.7 USD
126% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Apollo Medical Holdings Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for ASTH is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one ASTH stock?

The intrinsic value of one ASTH stock under the Base Case scenario is 48.67 USD.

Is ASTH stock undervalued or overvalued?

Compared to the current market price of 25.12 USD, Apollo Medical Holdings Inc is Undervalued by 48%.

Back to Top